These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33221953)

  • 1. Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation.
    Hayashi H; Iwasaki YK; Arai T; Mimuro R; Hachisuka M; Maru Y; Fujimoto Y; Oka E; Hagiwara K; Imori Y; Yamamoto T; Murata H; Yodogawa K; Takano H; Shimizu W
    Heart Vessels; 2021 May; 36(5):667-674. PubMed ID: 33221953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.
    van Velzen HG; Theuns DA; Yap SC; Michels M; Schinkel AF
    Am J Cardiol; 2017 Jan; 119(1):100-105. PubMed ID: 28247846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices.
    Kim BS; Chun KJ; Hwang JK; Park SJ; Park KM; Kim JS; On YK
    Medicine (Baltimore); 2016 Jul; 95(28):e4181. PubMed ID: 27428213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Higuchi S; Ejima K; Minami Y; Ooyabu K; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
    Heart Vessels; 2019 Mar; 34(3):527-537. PubMed ID: 30255478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
    Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
    Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
    Fumagalli C; Bonanni F; Beltrami M; Ruggieri R; Zocchi C; Tassetti L; Maurizi N; Berteotti M; Zampieri M; Argirò A; Lovero F; Tomberli A; di Bari M; Marchionni N; Pieragnoli P; Ricciardi G; Checchi L; Cappelli F; Fumagalli S; Olivotto I
    Int J Cardiol; 2023 Jun; 381():70-75. PubMed ID: 37061097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy.
    Aizawa Y; Tanimoto Y; Hirata Y; Fujisawa T; Fukuoka R; Nakajima K; Katsumata Y; Nishiyama T; Kimura T; Yuasa S; Kohno T; Kohsaka S; Murata M; Maekawa Y; Furukawa Y; Takatsuki S; Fukuda K
    Keio J Med; 2019 Dec; 68(4):87-94. PubMed ID: 30606897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy.
    Roh SY; Kim DH; Ahn J; Lee KN; Lee DI; Shim J; Choi JI; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):788-95. PubMed ID: 27062657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Zheng S; Jiang W; Dai J; Li K; Shi H; Wu W; Liu X; He B; Qiu X; Song Z
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):621-628. PubMed ID: 31930545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Costabel JP; Galve E; Terricabras M; Ametrano C; Ronderos R; Baranchuk A; Evangelista A; Avegliano G
    Echocardiography; 2018 Jul; 35(7):935-940. PubMed ID: 29505666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Lee SE; Park JK; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
    Heart; 2017 Oct; 103(19):1496-1501. PubMed ID: 28428444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of atrial fibrillation in hypertrophic cardiomyopathy.
    Guttmann OP; Pavlou M; O'Mahony C; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; Garcia-Pavia P; McKenna WJ; Omar RZ; Elliott PM;
    Heart; 2017 May; 103(9):672-678. PubMed ID: 27794017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
    Bunch TJ; Day JD; Olshansky B; Stolen KQ; Mullin CM;
    Heart Rhythm; 2009 Jan; 6(1):2-8. PubMed ID: 18996055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
    Tian H; Cui J; Yang C; Hu F; Yuan J; Liu S; Yang W; Jiang X; Qiao S
    BMC Cardiovasc Disord; 2018 Nov; 18(1):207. PubMed ID: 30390664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.